These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1237376)

  • 1. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
    Lance EM; Kremer M; Abbosh J; Jones VE; Knight S; Medawar PB
    Clin Exp Immunol; 1975 Jul; 21(1):1-12. PubMed ID: 1237376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toleracne to equine IgG after immunosuppression in patients with multiple sclerosis.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Postgrad Med J; 1976; 52(5 Suppl):136-8. PubMed ID: 1033536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro.
    Knight SC; Lance EM; Abbosh J; Munro A; O'Brien J
    Clin Exp Immunol; 1975 Jul; 21(1):23-31. PubMed ID: 1181076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Intensive immunosuppression in multiple sclerosis.
    Lance EM; Abbosh J; Kremer M; Jones V; Knight S; Medawar P
    Neurology; 1975 May; 25(5):491. PubMed ID: 1169713
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensive immunosuppression in the treatment of multiple sclerosis.
    Ring J; Seifert J; Lob G; Coulin K; Angstwurm H; Frick E; Brass B; Mertin J; Backmund H; Brendel W
    Lancet; 1974 Nov; 2(7889):1093-6. PubMed ID: 4139403
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Clin Exp Immunol; 1975 Jul; 21(1):13-22. PubMed ID: 810281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].
    Cendrowski W
    Postepy Hig Med Dosw; 1978; 32(4):513-22. PubMed ID: 724575
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine, combination immunosuppression, and posttransplant diabetes mellitus.
    Boudreaux JP; McHugh L; Canafax DM; Asher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1811-3. PubMed ID: 3079040
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic reactions to a horse globulin therapy and their prevention by induction of immunological tolerance.
    Ring J; Seifert J; Lob G; Hopf U; Land W; Brendel W
    Allergol Immunopathol (Madr); 1974; 2(2):93-8. PubMed ID: 4211785
    [No Abstract]   [Full Text] [Related]  

  • 12. A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
    Tourtellotte WW; Syndulko K; Baumhefner RW; Shapshak P; Osborne M
    Neurology; 1988 Jul; 38(7 Suppl 2):83-6. PubMed ID: 3386848
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive treatment of multiple sclerosis. 4. Results of treatment with azathioprine and antilymphocyte globulin (author's transl)].
    Frick E; Angstwurm H; Blomer R; Strauss G
    MMW Munch Med Wochenschr; 1977 Sep; 119(35):1111-4. PubMed ID: 408666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
    Cerilli GJ; Miller A; Hattan D
    Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
    [No Abstract]   [Full Text] [Related]  

  • 15. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunosuppressive treatment of multiple sclerosis].
    Frick E
    Nervenarzt; 1976 Jul; 47(7):424-8. PubMed ID: 958545
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serologic studies of patients under treatment with xenogenous antilymphocyte globulin].
    Hopf U; Fateh-Moghadam A; Land W; Brendel W
    Klin Wochenschr; 1970 Aug; 48(15):906-13. PubMed ID: 4996980
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: Immunotherapy for multiple sclerosis.
    Br Med J; 1975 Nov; 4(5995):486-7. PubMed ID: 1192142
    [No Abstract]   [Full Text] [Related]  

  • 19. [Compatibility of antihuman lymphocyte globulin (AHLG). Possible side effects and complications].
    Preussner S; Frick G; Rudolph W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):37-52. PubMed ID: 88389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.